Biomimetic Enzyme Barrier for Preventing Intestine-Derived LPS Induced Diseases

Cheng Zhao,Xiaoming Kao,Zhiwei Wang,Qinjie Liu,Jie Wu,Qiongyuan Hu,Xiuwen Wu,Jianan Ren
DOI: https://doi.org/10.1039/c9ra08721d
IF: 4.036
2020-01-01
RSC Advances
Abstract:Biomimetic enzyme barrier (BEB) encapsulated microcapsules with alginate shells were in situ fabricated with a microfluidic electrospray approach for preventing intestine-derived LPS induced diseases. As the alginate shells could protect the contents in gastric juice and release them in the intestine, the inner BEB could form a consecutive immune barrier on the surface of the intestine during the release. Through combining BEB with alkaline phosphatase, the immune barrier could degrade and prevent the permeation of lipopolysaccharide, which enhanced the intestinal barrier function. Thus, the BEB microcapsules were imparted with outstanding ability in preventing intestine-derived LPS induced diseases. Based on an in vivo study, we demonstrated that this BEB microcapsule could effectively protect organ function, restore intestinal barrier integrity, prevent the permeation of LPS and alleviate inflammation. Therefore, the generated microcapsules have potential for clinical applications.
What problem does this paper attempt to address?